Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model
Background and aimsPatients with chronic hepatitis B (CHB) in the immune tolerant (IT) phase were previously thought to have no or slight inflammation or fibrosis in the liver. In fact, some CHB patients with normal ALT levels still experience liver fibrosis. This study aimed to develop and validate...
Main Authors: | Shuo Li, Zhiguo Li, Hongbo Du, Xiaobin Zao, Da’nan Gan, Xianzhao Yang, Xiaoke Li, Yufeng Xing, Yong’an Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1137738/full |
Similar Items
-
Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma
by: Shuo Li, et al.
Published: (2023-06-01) -
Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma
by: Xu Cao, et al.
Published: (2022-09-01) -
Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis
by: Yuhao Yao, et al.
Published: (2022-11-01) -
A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels
by: Xiaoke Li, et al.
Published: (2021-06-01) -
Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review
by: Shihao Zheng, et al.
Published: (2024-04-01)